Richard S. Vander Heide, M.D., Ph.D.

Administration	Basic Sciences	Clinical Sciences	Centers of Excellence
Admissions Alumni Affairs Community and Minority Health Education Computer Support Continuing Education Dean's Office Faculty & Institutional Affairs Fiscal Affairs Libraries Medical Education Research Student Affairs	Biochemistry & Molecular Biology Cell Biology & Anatomy Genetics Microbiology, Immunology & Parasitology Pharmacology Physiology	Anesthesiology Dermatology Family Medicine Internal Medicine Emergency Medicine Gastroenterology Physical Medicine & Rehabilitation Neurology Neurosurgery OB/GYN Ophthalmology Orthopaedics Otorhinolaryngology Pathology Pediatrics Psychiatry Radiology Surgery Urology	Alcohol and Drug Abuse Center Cardiovascular Center Center on Healthy Aging Center for Molecular and Human Genetics Epilepsy Center Eye Center Ernest N. Morial Asthma, Allergy, and Respiratory Disease Center Gene Therapy Program Low Vision Center Neurosciences Center The Research Institute For Children Stanley S. Scott Cancer Center

	Richard S. Vander Heide, M.D., Ph.D. Jack Perry Strong Professor and Head Department of Pathology 1901 Perdido Street New Orleans, LA 70112 Phone: (504) 568-6033 rvand3@lsuhsc.edu
Degrees	1981 Bachelor of Science (B.S.) Degree, Calvin College, Grand Rapids, Michigan 1986 Doctor of Philosophy (Ph.D.) Degree, Northwestern University, Experimental Pathology, Chicago, Illinois 1989 Doctor of Medicine (M.D.) Degree, Northwestern University Medical School, Chicago, Illinois
Bio	Dr. Vander Heide completed his residency in Anatomic Pathology at Duke University from 1989-1993. His first position was at Wayne State University Medical School in Detroit, Michigan where he was the Residency Program Director for 5 years and was named as Best Pathology instructor by the sophomore medical student class 3 times. He was Chief of Pathology at the John D. Dingell VA Medical Center from 2000-2009. His primary research interest is myocardial cell injury and adaptation; specifically in response to ischemia/reperfusion injury.
Clinical Interests	Cardiovascular pathology, autopsy pathology
Research Interests	Ischemia/Reperfusion Injury, Novel Drug Delivery for Ischemic Injury Cell Signaling
Teaching Activities	Medical school education and teaching
Selected Publications	L’Ecuyer T, Sanjeev S, Thomas R, Das L, Campbell W, Novak R, Vander Heide RS: DNA damage is an early event in doxorubicin-induced cardiomyocyte death. Am J Physiol Heart Circ Physiol 291:H1273-H1280, 2006. Basson MD, Sanders MA, Gomez R, Hatfield J, Vander Heide RS, Thamilselvan V, Zhang J, and Mary F. Walsh: Focal adhesion kinase protein levels in gut epithelial motility. Am J Physiol Gastrointest Liver Physiol 293(3): G491-499, 2006. Spears R, Prcevski P, Jiang A, Brereton GJ, Vander Heide R: Intracoronary aqueous oxygen perfusion, performed 24 h after the onset of postinfarction reperfusion, experimentally reduces infarct size and improves left ventricular function. Int J Cardiol 113(3):371-375, 2006. Wei H, Vander Heide RS: Heat stress activates AKT via focal adhesion kinase mediated pathway in neonatal rat ventricular myocytes. Am J Physiol Heart Circ Physiol, 295: H561-H568, 2008. Walsh MF, Ampasala DR, Hatfield J, VanderHeide R, Rishi AK, Basson MD. TGF-b stimulates intestinal epithelial FAK synthesis via Smad- and p38-dependent mechanisms. Am J Path August 173(2): 385-399, 2008.
Additional Info	Diplomate, American Board of Pathology, 1993 Fellow, College of American Pathologists

Jack Perry Strong Professor and Head Department of Pathology